| Pharmacopolitics: drug regulation in the United States and Germany AA Daemmrich Chemical Heritage Foundation, 2004 | 326 | 2004 |
| A collaboratively-derived science-policy research agenda WJ Sutherland, L Bellingan, JR Bellingham, JJ Blackstock, RM Bloomfield, ... PloS one 7 (3), e31824, 2012 | 168 | 2012 |
| A tale of two experts: thalidomide and political engagement in the United States and West Germany A Daemmrich Social History of Medicine 15 (1), 137-158, 2002 | 104 | 2002 |
| The tragedy of the commoners: biotechnology and its publics A Sagar, A Daemmrich, M Ashiya Nature Biotechnology 18 (1), 2-4, 2000 | 98 | 2000 |
| The evidence does not speak for itself: Expert witnesses and the organization of DNA-typing companies A Daemmrich Social Studies of Science 28 (5-6), 741-772, 1998 | 76 | 1998 |
| Invention, innovation systems, and the Fourth Industrial Revolution A Daemmrich Technology & Innovation 18 (4), 257-265, 2017 | 74 | 2017 |
| The political economy of healthcare reform in China: negotiating public and private A Daemmrich SpringerPlus 2, 1-13, 2013 | 68 | 2013 |
| Toxic bodies/toxic environments: An interdisciplinary forum JA Roberts, N Langston, M Egan, S Frickel, L Nash, B Allen, SA Vogel, ... Environmental History 13 (4), 629-703, 2008 | 61 | 2008 |
| Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany A Daemmrich, G Krücken Science as Culture 9 (4), 505-534, 2000 | 59 | 2000 |
| A rising drug industry AA DAEMMRICH, ME Bowden Chemical & engineering news 83 (25), 28-42, 2005 | 51 | 2005 |
| Healthcare reform in the United States and China: pharmaceutical market implications A Daemmrich, A Mohanty Journal of pharmaceutical policy and practice 7 (1), 9, 2014 | 37 | 2014 |
| US healthcare reform and the pharmaceutical industry A Daemmrich Harvard Business School 14, 12-015, 2011 | 35 | 2011 |
| The welfare state as an investment strategy: Denmark’s flexicurity policies A Daemmrich, T Bredgaard | 31 | 2013 |
| Where is the Pharmacy to the World?: International Regulatory Variation and Pharmaceutical Industry Location AA Daemmrich Harvard Business School, 2009 | 19 | 2009 |
| Emergence of pharmaceutical science and industry: 1870–1930 A Daemmrich, ME Bowden Chem Eng News 83, 2005 | 17 | 2005 |
| Synthesis by microbes or chemists? Pharmaceutical research and manufacturing in the antibiotic era A Daemmrich History and Technology 25 (3), 237-256, 2009 | 16 | 2009 |
| Brazil: Leading the brics? AA Daemmrich, A Musacchio | 13 | 2011 |
| Risk Frameworks and Biomonitoring: Distributed Regulation of Synthetic Chemicals in Humans A Daemmrich Environmental History 13 (4), 684-694, 2008 | 13 | 2008 |
| Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate A Daemmrich Pharmacy in history 45 (1), 3-17, 2003 | 13 | 2003 |
| Pharmaceutical manufacturing in America: a brief history A Daemmrich Pharmacy in History 59 (3), 63-72, 2017 | 11 | 2017 |
